Effect of fenfluramine-induced increases in serotonin release on [18F]MPPF binding: A continuous infusion PET study in conscious monkeys
Abstract
[18F]MPPF is a selective and reversible antagonist to the serotonin‐1A (5‐HT1A) receptor. The aim of the present study was to investigate whether the binding of [18F]MPPF is sensitive to increases in 5‐HT levels. We used the 5‐HT releasing agent and reuptake inhibitor fenfluramine (FEN) to increase the concentration of 5‐HT. [18F]MPPF binding was assessed using positron emission tomography (PET) in conscious monkeys. Possible effects of blood flow on ligand binding were excluded by using a bolus‐infusion paradigm. Control scans were obtained to assess the state of ligand equilibrium. FEN (5 or 10 mg/kg, i.v.) was administered between 90 and 130 min after the start of the [18F]MPPF infusion. The binding potential (BP) was calculated for an early interval (30 min preceding FEN administration) and late interval (20–50 min after administration of FEN). Microdialyses results showed a 20‐ and 35‐fold increase in extracellular 5‐HT levels in the prefrontal cortex after injection of FEN at a dose of 5 mg/kg and 10 mg/kg respectively. However, despite these large increases in 5‐HT levels, no differences in BP were found between the control and FEN scans. These results may imply that the majority of 5‐HT1A receptors is in the low affinity state in the living brain. Synapse 59:18–26, 2006.Keywords
This publication has 52 references indexed in Scilit:
- Effect of Increased Serotonin Levels on [18F]MPPF Binding in Rat Brain: Fenfluramine vs the Combination of Citalopram and KetanserinNeuropsychopharmacology, 2005
- Rat‐PET study without anesthesia: Anesthetics modify the dopamine D1 receptor binding in rat brainSynapse, 2004
- In vivo vulnerability to competition by endogenous dopamine: Comparison of the D2 receptor agonist radiotracer (–)‐N‐[11C]propyl‐norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]‐racloprideSynapse, 2004
- Specific Binding of [11C]Raclopride and N-[3H]Propyl-Norapomorphine to Dopamine Receptors in Living Mouse Striatum: Occupancy by Endogenous Dopamine and Guanosine Triphosphate–Free G ProteinJournal of Cerebral Blood Flow & Metabolism, 2002
- Effects of aging on 5‐HT1A receptors and their functional response to 5‐HT1a agonist in the living brain: PET study with [carbonyl‐11C]WAY‐100635 in conscious monkeysSynapse, 2001
- [18F]p-MPPF: A Radiolabeled Antagonist for the Study of 5-HT1A Receptors with PETNuclear Medicine and Biology, 2000
- 5‐HT1A receptor agonist‐antagonist binding affinity difference as a measure of intrinsic activity in recombinant and native tissue systemsBritish Journal of Pharmacology, 2000
- Assessment of Dynamic Neurotransmitter Changes with Bolus or Infusion Delivery of Neuroreceptor LigandsJournal of Cerebral Blood Flow & Metabolism, 1998
- The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranesEuropean Journal of Pharmacology: Molecular Pharmacology, 1995
- Brain activation study by use of positron emission tomography in unanesthetized monkeysNeuroscience Letters, 1994